IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 43 filers reported holding IMPEL NEUROPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,836 | -66.1% | 25,200 | 0.0% | 0.00% | – |
| Q2 2023 | $32,004 | -9.3% | 25,200 | 0.0% | 0.00% | – |
| Q1 2023 | $35,280 | -87.5% | 25,200 | -66.4% | 0.00% | – |
| Q4 2022 | $281,250 | +38.5% | 75,000 | +79.9% | 0.00% | – |
| Q3 2022 | $203,000 | -47.8% | 41,700 | 0.0% | 0.00% | – |
| Q2 2022 | $389,000 | -66.1% | 41,700 | -76.8% | 0.00% | – |
| Q1 2022 | $1,147,000 | -21.3% | 180,045 | +6.6% | 0.00% | – |
| Q4 2021 | $1,458,000 | -7.2% | 168,938 | +31.0% | 0.00% | – |
| Q3 2021 | $1,571,000 | +283.2% | 128,974 | +178.6% | 0.00% | – |
| Q2 2021 | $410,000 | – | 46,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NVP Associates, LLC | 3,077,198 | $1,323,195 | 1.18% |
| 5AM Venture Management, LLC | 2,884,791 | $1,240,460 | 0.36% |
| venBio Partners LLC | 2,759,791 | $1,186,710 | 0.34% |
| Vivo Capital, LLC | 2,884,789 | $1,240,459 | 0.14% |
| LASRY MARC | 225,874 | $97,126 | 0.10% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1,778,468 | 0.06% |
| DCF Advisers, LLC | 178,500 | $76,755 | 0.04% |
| EPIQ PARTNERS, LLC | 16,325 | $7,020 | 0.01% |
| MCDONALD PARTNERS LLC | 19,400 | $8,342 | 0.00% |
| XTX Topco Ltd | 21,222 | $9,125 | 0.00% |